December 5, 2005
NoAb BioDiscoveries Inc. announces the launch of a new assay: Metabolic Stability with Phase II Enzymes.
November 17, 2005
NoAb BioDiscoveries Inc. successfully conducted a series of plasma and cerebral spinal fluid pharmaceutical studies for Allon Therapeutics Inc.
May 6, 2005
NoAb Biodiscoveries Inc. announces the launch of in vivo Serial Cerebral Spinal Fluid collection for the determination of brain penetration of drugs.
March 29, 2004
NoAb BioDiscoveries Inc. Launches Zero-Trap™ Microwell Plates to Eliminate Non-Specific Binding in Homogeneous Assays
November 3, 2003
NoAb BioDiscoveries Inc. Licenses Lipid Vesicle Technology from CytoPhotonics Inc.
September 22, 2003
NoAb BioDiscoveries Inc. Launches UniMAC™, a Universal Material Activation technology for Microplates
January 6, 2003
NoAb BioDiscoveries Signs Strategic Alliance Agreement with MCR Research Inc.
September, 2001
NoAb BioDiscoveries to Provide Drug Discovery Services to Pharmaceutical Industry
